GGrantIndex
← Search

CORE--RADIATION RESOURCE FACILITY

$78,870P30FY2001CANIH

Case Western Reserve University, Cleveland OH

Investigators

Linked publications, trials & patents

Trial NCT05340673Trial NCT05198830Trial NCT02590107Trial NCT02535325Trial NCT02451124Trial NCT02419846Trial NCT02417948Trial NCT02392377Trial NCT02388932Trial NCT02383433Trial NCT02375477Trial NCT02354326Trial NCT02345460Trial NCT02342730Trial NCT02337465Trial NCT02327390Trial NCT02319889Trial NCT02307474Trial NCT02287636Trial NCT02252393Trial NCT02181478Trial NCT02179762Trial NCT02163317Trial NCT02158767Trial NCT02153450Trial NCT02135562Trial NCT02131207Trial NCT02129582Trial NCT02129569Trial NCT02129517Trial NCT02129218Trial NCT02128373Trial NCT02108587Trial NCT02100423Trial NCT02084147Trial NCT02082405Trial NCT02081794Trial NCT02079155Trial NCT02073097Trial NCT02073045Trial NCT02071901Trial NCT02070458Trial NCT02070419Trial NCT02055586Trial NCT02037048Trial NCT01973062Trial NCT01959490Trial NCT01959477Trial NCT01954784Trial NCT01954732Trial NCT01951885Trial NCT01939028Trial NCT01928485Trial NCT01894061Trial NCT01408043Trial NCT00991991Trial NCT00970684Trial NCT00961220Trial NCT00956475Trial NCT00952939Trial NCT00949247Trial NCT00945061Trial NCT00941720Trial NCT00941070Trial NCT00939510Trial NCT00918892Trial NCT00918788Trial NCT00918658Trial NCT00918216Trial NCT00910039Trial NCT00909662Trial NCT00908739Trial NCT00908141Trial NCT00907699Trial NCT00905086Trial NCT00900133Trial NCT00899158Trial NCT00899132Trial NCT00898573Trial NCT00898274Trial NCT00897143Trial NCT00892385Trial NCT00873600Trial NCT00873002Trial NCT00866320Trial NCT00856115Trial NCT00853021Trial NCT00842452Trial NCT00809185Trial NCT00796978Trial NCT00795678Trial NCT00769951Trial NCT00769249Trial NCT00752323Trial NCT00740961Trial NCT00736216Trial NCT00735514Trial NCT00733252Trial NCT00732745Trial NCT00732173

Abstract

DESCRIPTION (provided by applicant): The Radiation Resources Core Facility serves Cancer Center members by (1) maintaining and operating ionizing radiation-producing devices; (2) training new users in proper operation of the equipment; and (3) keeping records of usage. The facility provides an essential service and has had significant impact on the research of two types of cancer researchers: those studying the cancer-causing and cancer-treating actions of radiation, and those with primary interests in other topics for whom radiation is a useful tool, e.g., for killing cells to prepare feeder layers. Direction for the Facility is the responsibility of Dr. Nancy L. Oleinick, who has been the director since the establishment of the Cancer Center. Day-to-day management is by Mr. John Mulvihill, a radiation physicist who has efficiently operated the facility since 1988. Oversight is provided by a Scientific Advisory Board and by the Cancer Center. The facility is used by cancer researchers from diverse departments and representing all but one of the programs of the Cancer Center. The Cs-137 and Co-60 gamma-irradiators are the primary equipment and together are used 60-80 times per month; representing up to 30 percent and 50 percent of maximum capacity, respectively. In response to requests from users and on the advice of the facility's Scientific Advisory Board, a new low-dose-rate Ir-192 irradiator will be available in a tissue culture incubator, broadening the ability to mimic brachytherapy or chronic environmental exposures. About half of the usage is by Cancer Center members, and most usage (72 percent) supports peer-reviewed, funded research. Since this is the only facility of its type at the university, it must be available to all researchers; however, Cancer Center members who charge their usage to an NIH grant receive a 50 percent discount on their fees. The overall rate of usage indicates that the Core Facility is essential for many cancer researchers.

View original record on NIH RePORTER →